Acumen Pharmaceuticals, Inc.
$3.10
+0.02 (+0.81%)
Price as of Aug 25, 2026 market close
Performance
- 1 Month
- +40.9%
- 3 Months
- +28.1%
- YTD
- +46.9%
- 1 Year
- +102.6%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 85.0%
- Largest decline max drawdown, since Aug 2025
- -37.4%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.24
Own ABOS?
See how ABOS contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.